Skip to content

Assessment of Tremor Using SNUMAP Motion Sensing System

Quantitative Assessment of Tremor Using Portable Six-axis (Tri-axial Accelerometer and Tri-axial Gyroscope) Motion Sensing System

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01731145
Acronym
SNUMAP
Enrollment
187
Registered
2012-11-21
Start date
2014-08-31
Completion date
2015-02-28
Last updated
2015-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tremor

Keywords

Tremor, SNUMAP, accelerometry, gyroscope, clinical rating scale

Brief summary

The purpose of this study is to record and measure tremor using portable six-axis (tri-axial accelerometer and tri-axial gyroscope) motion sensing system.

Detailed description

SNUMAP system is portable, finger-worn, battery powered device that contains MEMS (micro-electro-mechanical system) hybrid motion sensor (three-axis accelerometer and three-axis gyroscope). The SNUMAP device consists of a wrist module and finger module, which attaches to an patients's finger and transmits three dimensional motions to a wrist module for storage and further analysis. The aims of this study is to assess tremor severity using tri-axial accelerometry and gyroscope to determine the reliability and the correlation with clinical measurements.

Interventions

DEVICESNUMAP

Portable six-axis (tri-axial accelerometer and tri-axial gyroscope) motion sensing system

Sponsors

Life Science Technology Inc.
CollaboratorINDUSTRY
Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age: 20-80 years * Patients with tremor (involuntary, rhythmic, oscillatory movement in one or more body part) * Subject who signed an informed consent

Exclusion criteria

* Pregnant or nursing woman. * Comorbid neurologic illnesses that impact the ability to perform the study tasks. * Subjects with medical condition that in the opinion of the investigator would affect his/her ability to participate in this study.

Design outcomes

Primary

MeasureTime frameDescription
3-D Accelerometric and gyroscope variables measured1 dayCorrelation between SNUMAP motion sensing system symptom assessment and clinical tremor rating scale (TRS) scores

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026